BC
BIOSIMILAR COLLABORATIONS IRELAND LIMITED
Has won 6 UK public-sector contracts worth £833.7m across 3 buyers, primarily NHS England North East and Yorkshire Health and Justice.
Active contracts
4
no new awards in 30d
Contracted (12m)
£820.6m
▲ 6147% vs prior 12m
Public buyers
3
stable this month
Top buyer share
94%
NHS England North East and Yorkshire Health and Justice
Buyer concentration
Each block sized by share of total award value. A dominant block signals dependency on one buyer.
Severe concentration. Top buyer alone = 94% of revenue.
NHS England North East and Yorkshire Health and Justice
£782.9m
94%NHS England
£50.8m
6%eTenderwales
—
0%Contracts won · 6 total · 4 active · 0 expired
Every contract award published under the Procurement Act.
| Title | Buyer | Award type | Value | Awarded | Status |
|---|---|---|---|---|---|
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 | NHS England North East and Yorkshire Health and Justice | Shared contract | £782.9m lot total · 5 suppliers | 31 Jul 2025 | pending |
| Project/Contract NHS National Framework for Denosumab Injection | NHS England | Shared contract | £37.7m lot total · 5 suppliers | 30 Sept 2025 | pending |
| NHS Branded Medicines Tranche Framework for London and South of England | NHS England | Shared contract | £13.1m lot total · 29 suppliers | 22 Jul 2024 | active |
| Biologic and Biosimilar Medicines | eTenderwales | Direct contract | — | — | active |
| NHS Branded Medicines Tranche Framework for London and South of England | NHS England | Direct contract | — | — | active |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 | NHS England | Shared contract | — lot total · 4 suppliers | — | active |